But, as Insider global editor-in-chief Nich Carlson writes here, a return to any sense of normality is likely a long way off, as the world awaits immunity testing, an effective treatment, and a vaccine. Here's the latest:
Blake also reported on the challenges Scanwell Health has faced in trying to make the first at-home test that can tell if you've had the coronavirus. It reveals a crucial roadblock to reopening the US, she reported.
Meanwhile, Hugh Langley reported that Alphabet's Verily told five US senators that it has run more than 7,000 tests for COVID-19 and plans to keep the mandatory Google sign-in. You can read his story and letter Verily sent here.
The stock market popped on Friday after it was reported that remdesivir, an antiviral drug from Gilead, had seen promising results. Andrew Dunn reported:
The UBS analyst Navin Jacob cautioned that the University of Chicago trial represented about 3% of Gilead's clinical-trial program. While Jacob said he was "encouraged" by the report, he also noted "many caveats" given the lack of a control group and no detailed data on how healthy or sick the patients were.
"No one's done all those pieces and then said 18 months," Porges said. "They've just effectively taken Tony Fauci's 'not for 18 months,' and that's become gospel."
Lastly, Morgan Stanley researchers this week released their own timeline for how they think all of the above will come together. You can read more on that here:
The COVID-19 pandemic has forced businesses all around the world to shut down their offices and tell employees to work from home.
Advertisement
Amazon, Facebook, and Google are just a few of the biggest companies to close down their offices all around the world, forcing senior executives to strategize the future of their firms while relying on video-calls and text messages.
Perlego – an online library startup dubbed the "Spotify of textbooks"– has analyzed the most popular books ordered by more than 600 C-suite executives using its platform.
Titles include bestsellers by the likes of Nike cofounder Phil Knight, Nobel Prize-winning economist Jean Tirole and Ben Horowitz, one of the best-known investors in Silicon Valley.
NewsletterSIMPLY PUT - where we join the dots to inform and inspire you. Sign up for a weekly brief collating many news items into one untangled thought delivered straight to your mailbox.